Bottom line
SHSAX vs VHT: the short answer
SHSAX (Blackrock Health Sciences Opportunities Portfolio) and VHT (Vanguard Health Care Index Fund) are both mutual funds.
But VHT is far broader, holding 407 positions to 155 for SHSAX, so beyond the top names it adds exposure SHSAX doesn't have.
VHT is cheaper at 0.09% vs 1.11% — a difference of $102 a year per $10,000 invested.
Over five years, VHT returned +7.2% a year vs +4.5% for SHSAX (reporting dates differ).
SHSAX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
SHSAX vs VHT side by side
| SHSAX | VHT | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | BlackRock | Vanguard |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 0.09% |
| Annual cost per $10k | $111 | $9 |
| 10-yr cost on $10k (prospectus) | $1,806 | $115 |
| Max front load | 5.25% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +9.9% | +2.7% |
| 5-yr return (annualized) | +4.5% | +7.2% |
| 10-yr return (annualized) | +9.0% | +8.8% |
| Best quarter | +17.5% | +16.5% |
| Worst quarter | −11.5% | −13.1% |
| Net assets (fund) | $5.9B | $19.0B |
| Number of holdings | 155 | 407 |
| Portfolio turnover | 49% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHSAX | VHT | Difference |
|---|---|---|---|
| 2024 | +3.9% | +2.7% | +1.2% |
| 2023 | +3.6% | +2.5% | +1.1% |
| 2022 | −5.9% | −5.5% | −0.4% |
| 2021 | +11.8% | +20.5% | −8.7% |
| 2020 | +19.5% | +18.2% | +1.3% |
| 2019 | +25.3% | +22.0% | +3.3% |
| 2018 | +8.0% | +5.6% | +2.4% |
| 2017 | +24.8% | +23.3% | +1.5% |
| 2016 | −6.1% | −3.3% | −2.7% |
| 2015 | +11.0% | +7.2% | +3.8% |
Source: Fund prospectus bar charts
Holdings overlap
18 of SHSAX's top 25 holdings also appear in VHT's top 25.
| Holding | SHSAX | VHT |
|---|---|---|
| Eli Lilly & Company | 12.29% | 14.04% |
| Johnson & Johnson | 8.77% | 8.47% |
| Unitedhealth Group Inc | 6.10% | 5.45% |
| Merck & Company Inc | 4.94% | 4.66% |
| Gilead Sciences Inc | 4.19% | 2.64% |
| Abbvie Inc | 3.94% | 6.09% |
| Amgen Inc | 3.37% | 2.87% |
| Thermo Fisher Scientific Inc | 3.02% | 2.93% |
| Vertex Pharmaceuticals Inc | 2.74% | 1.80% |
| Pfizer Inc | 2.61% | 2.35% |
| Edwards Lifesciences Corp | 2.51% | 0.79% |
| Danaher Corp | 2.00% | 1.84% |
| Abbott Laboratories | 1.97% | 2.35% |
| Intuitive Surgical Inc | 1.95% | 2.38% |
| Boston Scientific Corp | 1.59% | 1.13% |
Source: SEC Form N-PORT
SHSAX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
FAQ
What is the difference between SHSAX and VHT?
Which is cheaper, SHSAX or VHT?
Should I own both SHSAX and VHT?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.